Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,955 | 1,580 | 2,978 | 1,597 | 1,124 |
| Marketable Securities | 5,940 | 6,715 | 7,528 | 9,910 | 7,556 |
| Receivables | 135 | 254 | 480 | 770 | 341 |
| Other current assets | 2,046 | 2,633 | 2,253 | 1,921 | 765 |
| TOTAL | $10,076 | $11,182 | $13,239 | $14,198 | $9,786 |
| Non-Current Assets | |||||
| PPE Net | N/A | 74 | 83 | 89 | 97 |
| Investments And Advances | 3,265 | 3,265 | 3,265 | 3,265 | 3,265 |
| Other Non-Current Assets | 0 | 0 | 42 | 86 | 129 |
| TOTAL | $3,265 | $3,339 | $3,390 | $3,440 | $3,491 |
| Total Assets | $13,341 | $14,521 | $16,629 | $17,638 | $13,277 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,554 | 1,765 | 2,750 | 2,091 | 2,723 |
| TOTAL | $1,554 | $1,765 | $2,750 | $2,091 | $2,723 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,554 | $1,765 | $2,750 | $2,091 | $2,723 |
| Shareholders' Equity | |||||
| Common Shares | 263 | 249 | 209 | 166 | 70 |
| Retained earnings | -195,346 | -194,227 | -192,952 | -190,936 | -189,463 |
| Other shareholders' equity | -435 | -455 | -454 | -697 | -662 |
| TOTAL | $11,787 | $12,756 | $13,879 | $15,457 | $10,554 |
| Total Liabilities And Equity | $13,341 | $14,521 | $16,629 | $17,548 | $13,277 |